Is HemoHIM Safe for the Liver? What Clinical Research Shows

If you're considering HemoHIM, liver safety is a reasonable concern — especially after a 2023 case report from Hong Kong raised questions. Here's what the clinical evidence actually shows: controlled safety studies found no signs of liver toxicity, and the three herbs in HemoHIM have a long history of safe use. But one case deserves a closer look.

Quick Answer: Is HemoHIM Safe for the Liver?

Based on published clinical data, HemoHIM shows no evidence of hepatotoxicity (liver damage) in controlled studies. A randomized, double-blind, placebo-controlled trial published in the Journal of Medicinal Food found that participants taking HemoHIM for 8 weeks showed no significant changes in liver enzymes (AST, ALT) compared to the placebo group. A separate 13-week repeated dose toxicity study in animals also showed no hepatic abnormalities.

However, one case of acute hepatitis was reported in Hong Kong in 2023 after a patient consumed HemoHIM. This single case should be understood in context — read on for the full analysis.

What Clinical Studies Say About HemoHIM and the Liver

8-Week Human Safety Trial

The most relevant study for liver safety is the randomized, double-blind, placebo-controlled trial published in the Journal of Medicinal Food (2020). In this trial, 80 healthy adults were divided into HemoHIM and placebo groups for 8 weeks. Key liver safety findings:

• AST (aspartate aminotransferase): No significant difference between HemoHIM and placebo groups

• ALT (alanine aminotransferase): No significant difference — the primary marker for liver cell damage

• GGT (gamma-glutamyl transferase): Within normal range in both groups throughout the study

The study concluded that HemoHIM was "safe and well-tolerated" with no adverse effects on liver function at the recommended dosage. For a deeper dive into the full body of HemoHIM research, see our clinical studies overview.

13-Week Repeated Dose Toxicity Study

A preclinical safety evaluation published in Regulatory Toxicology and Pharmacology tested HemoHIM at doses up to 5,000 mg/kg/day for 13 weeks (far exceeding the recommended human dosage). The study included histopathological examination of liver tissue. Results showed no treatment-related hepatic lesions, no changes in liver weight, and normal liver enzyme levels across all dose groups.

The Hong Kong Case: What Actually Happened

In 2023, the Hong Kong Centre for Health Protection issued a public advisory about a case of acute hepatitis linked to HemoHIM consumption. This understandably raised concerns. Here's the important context:

• This was a single case report, not a clinical study. Single case reports can indicate a possible association but cannot establish causation.

• The patient's full medical history, concurrent medications, and other supplements were not publicly disclosed — all of which could be contributing factors.

• Idiosyncratic drug reactions (rare individual reactions) can occur with virtually any supplement or medication, including common ones like acetaminophen and green tea extract.

• The controlled clinical trial (80 participants, 8 weeks) showed no liver enzyme elevations — suggesting this may be an individual reaction rather than a systematic safety concern.

For a complete overview of all reported HemoHIM side effects and safety data, see our dedicated safety guide.

The Three Herbs in HemoHIM: Individual Liver Safety Profiles

HemoHIM is a patented extract of three traditional Korean medicinal herbs. Each has been studied individually for safety:

Angelica gigas (Korean Angelica)

Used for centuries in Korean traditional medicine (hanbang). Multiple studies have investigated its hepatoprotective (liver-protecting) properties. Research published in Food and Chemical Toxicology actually found that decursin, the active compound in Angelica gigas, showed liver-protective effects against chemical-induced liver damage in animal models.

Cnidium officinale (Chuan Xiong)

A well-established herb in both Korean and Chinese medicine. No reports of hepatotoxicity in its traditional use spanning hundreds of years. Its active compound, ligustilide, has been studied for anti-inflammatory properties that may benefit overall organ health.

Paeonia japonica (Japanese Peony)

Peony root extracts have actually been studied as potential liver protectants. Paeoniflorin, the primary bioactive compound, has demonstrated anti-inflammatory and hepatoprotective effects in published research. Learn more about all three HemoHIM ingredients and the patented extraction process.

Who Should Be Extra Cautious

While clinical data supports HemoHIM's general liver safety, certain groups should exercise additional caution and consult a healthcare provider before use:

• People with pre-existing liver conditions (hepatitis, fatty liver disease, cirrhosis)

• Those taking hepatotoxic medications (certain statins, acetaminophen at high doses, some antibiotics)

• Heavy alcohol consumers — alcohol itself stresses the liver, and adding any supplement warrants medical guidance

• Anyone taking multiple supplements simultaneously — the liver processes all supplements, and combining many products increases workload

How to Monitor Your Liver Health While Taking Supplements

Regardless of which supplements you take, monitoring liver health is a good practice:

1. Get a baseline liver panel before starting any new supplement

1. Recheck after 4-8 weeks to compare enzyme levels

1. Watch for warning signs: yellowing of skin or eyes (jaundice), dark urine, unusual fatigue, or upper right abdominal pain

1. Discontinue and consult a doctor immediately if you experience any of these symptoms

Bottom Line

The published clinical evidence supports HemoHIM's liver safety at recommended doses. The 8-week human trial found no liver enzyme changes, the 13-week animal toxicity study found no hepatic damage, and the three individual herbs each have established safety profiles with some evidence of hepatoprotective properties.

The Hong Kong case is a legitimate data point that warrants transparency, but a single case report does not override controlled clinical trial data. As with any supplement, use as directed, inform your doctor, and monitor your health. To understand what HemoHIM is and how it works, start with our complete guide.